The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials

J. Rahmani; N. Manzari; J. Thompson; S. K. Gudi; M. Chhabra; G. Naik; S. M. Mousavi; H. K. Varkaneh; C. Clark; Y. Zhang

doi:10.1007/s12094-019-02108-9

The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials

J. Rahmani, N. Manzari, J. Thompson, S. K. Gudi, M. Chhabra, G. Naik, S. M. Mousavi, H. K. Varkaneh, C. Clark, Y. Zhang^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

24 Citations (SciVal)

Original language	English
Pages (from-to)	37-49
Number of pages	13
Journal	Clinical and Translational Oncology
Volume	22
Issue number	1
DOIs	https://doi.org/10.1007/s12094-019-02108-9
Publication status	Published (VoR) - 1 Jan 2020

Keywords

BMI
Breast cancer
Glucose
Insulin
Ki-67
Metformin

Access to Document

10.1007/s12094-019-02108-9

Cite this

Rahmani, J., Manzari, N., Thompson, J., Gudi, S. K., Chhabra, M., Naik, G., Mousavi, S. M., Varkaneh, H. K., Clark, C., & Zhang, Y. (2020). The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials. Clinical and Translational Oncology, 22(1), 37-49. https://doi.org/10.1007/s12094-019-02108-9

@article{6e91160179024829bb4b81d446ba8d37,

title = "The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials",

keywords = "BMI, Breast cancer, Glucose, Insulin, Ki-67, Metformin",

author = "J. Rahmani and N. Manzari and J. Thompson and Gudi, {S. K.} and M. Chhabra and G. Naik and Mousavi, {S. M.} and Varkaneh, {H. K.} and C. Clark and Y. Zhang",

note = "Publisher Copyright: {\textcopyright} 2019, Federaci{\'o}n de Sociedades Espa{\~n}olas de Oncolog{\'i}a (FESEO).",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/s12094-019-02108-9",

language = "English",

volume = "22",

pages = "37--49",

journal = "Clinical and Translational Oncology",

issn = "1699-048X",

publisher = "Springer",

number = "1",

}

Rahmani, J, Manzari, N, Thompson, J, Gudi, SK, Chhabra, M, Naik, G, Mousavi, SM, Varkaneh, HK, Clark, C & Zhang, Y 2020, 'The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials', Clinical and Translational Oncology, vol. 22, no. 1, pp. 37-49. https://doi.org/10.1007/s12094-019-02108-9

TY - JOUR

T1 - The effect of metformin on biomarkers associated with breast cancer outcomes

T2 - a systematic review, meta-analysis, and dose–response of randomized clinical trials

AU - Rahmani, J.

AU - Manzari, N.

AU - Thompson, J.

AU - Gudi, S. K.

AU - Chhabra, M.

AU - Naik, G.

AU - Mousavi, S. M.

AU - Varkaneh, H. K.

AU - Clark, C.

AU - Zhang, Y.

PY - 2020/1/1

Y1 - 2020/1/1

KW - BMI

KW - Breast cancer

KW - Glucose

KW - Insulin

KW - Ki-67

KW - Metformin

UR - http://www.scopus.com/inward/record.url?scp=85064674494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064674494&partnerID=8YFLogxK

U2 - 10.1007/s12094-019-02108-9

DO - 10.1007/s12094-019-02108-9

M3 - Article

C2 - 31006835

AN - SCOPUS:85064674494

SN - 1699-048X

VL - 22

SP - 37

EP - 49

JO - Clinical and Translational Oncology

JF - Clinical and Translational Oncology

IS - 1

ER -

The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials

Keywords

Access to Document

Other files and links

Fingerprint

Cite this